WO2004012766A1 - Procede de correction de reactions immunitaires pathologiques et preparation medicinale - Google Patents
Procede de correction de reactions immunitaires pathologiques et preparation medicinale Download PDFInfo
- Publication number
- WO2004012766A1 WO2004012766A1 PCT/RU2002/000367 RU0200367W WO2004012766A1 WO 2004012766 A1 WO2004012766 A1 WO 2004012766A1 RU 0200367 W RU0200367 W RU 0200367W WO 2004012766 A1 WO2004012766 A1 WO 2004012766A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antibodies
- anτiτel
- mixture
- πuτem
- φηο
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Definitions
- the invention is subject to the field of medicine and may be used for the treatment of psychological immune reactions associated with inflammatory, including autoimmune.
- ⁇ eshenie ⁇ s ⁇ avlenn ⁇ y task ⁇ bes ⁇ echivae ⁇ sya ⁇ em, ch ⁇ for ⁇ e ⁇ tsii ⁇ a ⁇ l ⁇ giches ⁇ i ⁇ immunny ⁇ ⁇ ea ⁇ tsy is ⁇ lzuyu ⁇ a ⁇ ivi ⁇ vannuyu ⁇ mu sve ⁇ maly ⁇ d ⁇ z m ⁇ n ⁇ l ⁇ nalny ⁇ , ⁇ li ⁇ l ⁇ nalny ⁇ or es ⁇ es ⁇ venny ⁇ an ⁇ i ⁇ el ⁇ tsi ⁇ inam, ⁇ eguli ⁇ uyuschim ⁇ echenie v ⁇ s ⁇ ali ⁇ elny ⁇ ⁇ tsess ⁇ v in ⁇ m including au ⁇ immunn ⁇ g ⁇ v ⁇ s ⁇ aleniya, ⁇ ig ⁇ vlennuyu ⁇ u ⁇ em mn ⁇ g ⁇ a ⁇ n ⁇ g ⁇ ⁇ sled ⁇ va ⁇ el
- a mixture of active antibodies can be used for various quotes that regulate the flow of the process.
- the predominant use of the mixture is various, preferably commercially available, homogenous dilutions.
- the medicinal product is prepared by the following process.
- the non-recombinant human factor does not result in the loss of alpha, which is consumed in the social system, which is cleaned and is immune to at least 97% of the disease.
- the resulting immune antibodies cleans by the method of affinity chromatography with protein ⁇ .
- the current processing in the process of reducing the concentration is also possible to carry out ultrasound, electric or other physical interference.
- the analgesic effect of the drug on the painful sensitivities of the wide range of tissues for the action of painful stimuli was studied on the model of “hot plate”. Lively placed on a hot plate and registered latent time 4 stays on the plate for the proximity of the extremity. The indicators of registrations were observed after 3 hours, 1 and 3 days after the introduction of phylogen.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA20041210914A UA76640C2 (ru) | 2002-08-02 | 2002-02-08 | Способ коррекции патологических иммунных реакций и гомеопатическое лекарственное средство |
US10/522,651 US20060153845A1 (en) | 2002-08-02 | 2002-08-02 | Method for correcting immune respones and medical agent |
EP02759005A EP1550460A4 (en) | 2002-08-02 | 2002-08-02 | METHOD FOR CORRECTING PATHOLOGICAL IMMUNE REACTIONS AND MEDICINAL PREPARATION |
EA200500101A EA008605B1 (ru) | 2002-08-02 | 2002-08-02 | Лекарственное средство для коррекции патологических иммунных реакций |
PCT/RU2002/000367 WO2004012766A1 (fr) | 2002-08-02 | 2002-08-02 | Procede de correction de reactions immunitaires pathologiques et preparation medicinale |
AU2002325433A AU2002325433A1 (en) | 2002-08-02 | 2002-08-02 | Method for correcting immune responses and medicinal agent |
IL16626905A IL166269A0 (en) | 2002-08-02 | 2005-01-06 | A pharmaceutical composition containing an activated form of diluted antibodies to ?-tnf |
US11/699,091 US20070141058A1 (en) | 2002-08-02 | 2007-01-30 | Method of correcting immunopathological reactions and a medicament |
US14/021,844 US20140010819A1 (en) | 2002-08-02 | 2013-09-09 | Method for correcting immunopathological reactions and a medicament |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU2002/000367 WO2004012766A1 (fr) | 2002-08-02 | 2002-08-02 | Procede de correction de reactions immunitaires pathologiques et preparation medicinale |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/699,091 Division US20070141058A1 (en) | 2002-08-02 | 2007-01-30 | Method of correcting immunopathological reactions and a medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004012766A1 true WO2004012766A1 (fr) | 2004-02-12 |
WO2004012766A8 WO2004012766A8 (fr) | 2005-03-03 |
Family
ID=31492975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU2002/000367 WO2004012766A1 (fr) | 2002-08-02 | 2002-08-02 | Procede de correction de reactions immunitaires pathologiques et preparation medicinale |
Country Status (7)
Country | Link |
---|---|
US (3) | US20060153845A1 (ru) |
EP (1) | EP1550460A4 (ru) |
AU (1) | AU2002325433A1 (ru) |
EA (1) | EA008605B1 (ru) |
IL (1) | IL166269A0 (ru) |
UA (1) | UA76640C2 (ru) |
WO (1) | WO2004012766A1 (ru) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
UA76640C2 (ru) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Способ коррекции патологических иммунных реакций и гомеопатическое лекарственное средство |
UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
WO2010134086A1 (en) * | 2009-05-19 | 2010-11-25 | Rajesh Shah | Medicinal formulation containing selected cytokines |
US8974771B2 (en) * | 2010-03-09 | 2015-03-10 | Penn-Century, Inc. | Apparatus and method for aerosol delivery to the lungs or other locations of the body |
EP2593474A2 (en) | 2010-07-15 | 2013-05-22 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
ES2440393R1 (es) | 2010-07-15 | 2014-10-10 | Oleg Iliich Epshtein | Un método para aumentar el efecto de una forma activada potenciada de un anticuerpo |
ITTO20110628A1 (it) * | 2010-07-15 | 2012-01-16 | Oleg Iliich Epshtein | Composizione farmaceutica di combinazione e metodi per trattare patologie funzionali o stati patologici del tratto gastrointestinale |
BR112013000841A2 (pt) * | 2010-07-15 | 2016-06-07 | Oleg Lliich Epshtein | composições farmacêuticas, métodos de tratamento da obesidade e distúrbios metabólicos relacionados, de redução da massa corpórea de mamífero, do crescimento da massa corpórea de mamífero, do consumo de comida em mamífero, de trtamento de paciente de adicção de substância psicoativa, de adicção de substância psicoativa e uso de forma ativada-potencializada de anticorpo para receptor de canabinoide humano. |
MX2013000807A (es) | 2010-07-21 | 2013-10-28 | Oleg Iliich Epshtein | Un metodo para el tratamiento del trastorno de hiperactividad con deficit de atencion. |
EA030513B1 (ru) * | 2010-08-06 | 2018-08-31 | Олег Ильич ЭПШТЕЙН | Комбинированная фармацевтическая композиция и способ лечения и профилактики инфекционных заболеваний |
RU2535033C2 (ru) * | 2010-08-06 | 2014-12-10 | Олег Ильич Эпштейн | Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида |
WO2013179302A1 (en) | 2012-05-15 | 2013-12-05 | Rajesh Shah | Oral anti-inflammatory formulation comprising potentised cytokine |
RU2013111962A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
RU2013111961A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU96118134A (ru) * | 1994-02-07 | 1998-12-27 | Кноль Аг | Применение антител против фактора некроза опухоли в качестве лекарственного средства для лечения заболеваний, связанных с повышенным уровнем интерлейкина-6 в сыворотке |
DE19746868A1 (de) * | 1997-10-23 | 1999-04-29 | Knoll Ag | Verwendung von TNF-Antagonisten als Arzneimittel zur Behandlung von septischen Erkrankungen |
WO2001097842A1 (fr) * | 2000-06-20 | 2001-12-27 | Oleg Iliich Epshtein | Procede de traitement d'un syndrome pathologique et produit medicamenteux |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
US4987127A (en) * | 1989-01-31 | 1991-01-22 | Dal Sirany | Method of treating a virus outbreak |
GB8905400D0 (en) * | 1989-03-09 | 1989-04-19 | Jonker Margreet | Medicaments |
US5698195A (en) * | 1991-03-18 | 1997-12-16 | New York University Medical Center | Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies |
EP0663836B1 (en) * | 1992-10-08 | 1997-07-09 | The Kennedy Institute Of Rheumatology | Treatment of autoimmune and inflammatory disorders |
US5879677A (en) * | 1992-12-09 | 1999-03-09 | The Scripps Research Institute | Method for inhibition of cerebral tissue factor mediated reperfusion damage |
IT1261849B (it) * | 1993-09-02 | 1996-06-03 | Avantgarde Spa | Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici. |
WO1995026325A2 (en) * | 1994-03-25 | 1995-10-05 | Isotechnika Inc. | Enhancement of the efficacy of drugs by deuteration |
US5629286A (en) * | 1994-03-31 | 1997-05-13 | Brewitt; Barbara | Homeopathic dilutions of growth factors |
US20010006637A1 (en) * | 1996-04-19 | 2001-07-05 | Tohru Akahoshi | Rheumatoid arthritis remedy containing anti-il-8 antibody as active ingredient |
IL118096A0 (en) * | 1996-05-01 | 1996-09-12 | Yeda Res & Dev | Antibodies against interferon alpha/beta receptor |
RU2201255C1 (ru) * | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции сосудистого тонуса |
UA76640C2 (ru) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Способ коррекции патологических иммунных реакций и гомеопатическое лекарственное средство |
-
2002
- 2002-02-08 UA UA20041210914A patent/UA76640C2/ru unknown
- 2002-08-02 WO PCT/RU2002/000367 patent/WO2004012766A1/ru not_active Application Discontinuation
- 2002-08-02 EA EA200500101A patent/EA008605B1/ru not_active IP Right Cessation
- 2002-08-02 AU AU2002325433A patent/AU2002325433A1/en not_active Abandoned
- 2002-08-02 US US10/522,651 patent/US20060153845A1/en not_active Abandoned
- 2002-08-02 EP EP02759005A patent/EP1550460A4/en not_active Withdrawn
-
2005
- 2005-01-06 IL IL16626905A patent/IL166269A0/xx unknown
-
2007
- 2007-01-30 US US11/699,091 patent/US20070141058A1/en not_active Abandoned
-
2013
- 2013-09-09 US US14/021,844 patent/US20140010819A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU96118134A (ru) * | 1994-02-07 | 1998-12-27 | Кноль Аг | Применение антител против фактора некроза опухоли в качестве лекарственного средства для лечения заболеваний, связанных с повышенным уровнем интерлейкина-6 в сыворотке |
DE19746868A1 (de) * | 1997-10-23 | 1999-04-29 | Knoll Ag | Verwendung von TNF-Antagonisten als Arzneimittel zur Behandlung von septischen Erkrankungen |
WO2001097842A1 (fr) * | 2000-06-20 | 2001-12-27 | Oleg Iliich Epshtein | Procede de traitement d'un syndrome pathologique et produit medicamenteux |
Non-Patent Citations (1)
Title |
---|
See also references of EP1550460A4 * |
Also Published As
Publication number | Publication date |
---|---|
US20140010819A1 (en) | 2014-01-09 |
US20070141058A1 (en) | 2007-06-21 |
WO2004012766A8 (fr) | 2005-03-03 |
AU2002325433A8 (en) | 2004-02-23 |
EP1550460A1 (en) | 2005-07-06 |
IL166269A0 (en) | 2006-01-15 |
EA008605B1 (ru) | 2007-06-29 |
UA76640C2 (ru) | 2006-08-15 |
EA200500101A1 (ru) | 2005-08-25 |
EP1550460A4 (en) | 2006-03-22 |
AU2002325433A1 (en) | 2004-02-23 |
US20060153845A1 (en) | 2006-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005000350A1 (en) | Medication and method for treating pathological syndrome | |
US6294171B2 (en) | Methods for treating disease states comprising administration of low levels of antibodies | |
WO2004012766A1 (fr) | Procede de correction de reactions immunitaires pathologiques et preparation medicinale | |
WO2004012764A1 (fr) | Medicament et procede de traitement des maladies de la prostate | |
WO2003055519A1 (fr) | Agent pharmaceutique et methode de traitement de maladies s'accompagnant de troubles du tonus vasculaire | |
WO2001097842A1 (fr) | Procede de traitement d'un syndrome pathologique et produit medicamenteux | |
US20150023972A1 (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
JP2016210787A (ja) | 組み合わせ医薬組成物及び胃腸管の機能的な疾患又は状態を治療する方法 | |
WO2004012767A1 (fr) | Preparation medicinale et procede de traitement de dyserections | |
US9913904B2 (en) | Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists | |
RU2187334C2 (ru) | Способ коррекции нарушенного иммунного гомеостаза и лекарственное средство | |
AU2003202093B2 (en) | Treatment of MS with goat serum | |
AU2003202093A1 (en) | Treatment of MS with goat serum | |
WO2003055518A1 (fr) | Procede de traitement d'etats immuno-pathologiques et medicament correspondant | |
WO2003040723A1 (fr) | Procede de rehabilitation de l'organisme en cas d'infection virale lente | |
US20140099328A1 (en) | Antibody product comprising n specific antibodies | |
WO2003077946A1 (fr) | Agent pharmaceutique et methode de traitement d'un syndrome pathologique associe a hemodyscrasia | |
US20030003110A1 (en) | Immunomodulatory effective compositions, methods for the production thereof and their use | |
WO2003037372A1 (fr) | Procede de retablissement de processus physiologiques perturbes et medicament | |
RU2500427C2 (ru) | Лекарственное средство для лечения функциональных нарушений желудочно-кишечного тракта и способ лечения функциональных нарушений желудочно-кишечного тракта | |
WO2004012765A1 (fr) | Preparation medicinale et procede de traitement d'un syndrome pathologique determine par une perturbation de l'hematopoiese | |
WO2003055517A1 (fr) | Procede de correction de la reponse immunitaire et medicament | |
RU2532323C2 (ru) | Лекарственное средство для лечения патологического синдрома и способ лечения функциональных нарушений кишечника | |
AU2002248189B2 (en) | Methods for treating disease states comprising administration of low levels of antibodies | |
AU2002248189A1 (en) | Methods for treating disease states comprising administration of low levels of antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 166269 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2006153845 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10522651 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200500101 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002759005 Country of ref document: EP |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 07/2004 UNDER (71, 72) ADD "EPSHTEIN, OLEG ILIICH, ¢RU/RU!; 103064 MOSCOW, B. KAZENNY PER. D.4, KV.41 (RU)"; UNDER (71, 72) DELETE "GOLDBERG, EVGENY DANILOVICH AND DYGAY, ALEXANDR MIKHAILOVICH"; UNDER (71) ADD "GOLDBERG, EVGENY DANILOVICH AND DYGAY, ALEXANDR MIKHAILOVICH" |
|
WWP | Wipo information: published in national office |
Ref document number: 2002759005 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10522651 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |